Q:What Action Did The Fda Take? A: The FDA issued a public health advisory concerning the use of Vioxx. This advisory is based on Merck voluntarily withdrawing Vioxx from the market due to safety concerns.
Q:Why Wasn't The Approve Trial Stopped Earlier? A: The APPROVe trial began enrollment in 2000 and was being monitored by an independent data safety monitoring board (DSMB). It was not stopped earlier because the …
More
Q:What Are Nsaids? A: NSAIDs are a large group of drugs that have painrelieving (analgesic) and fever reducing (antipyretic) effects, as well as the effect of reducing inflammation …
More
Q:What Is Vioxx? A: Vioxx (rofecoxib) is a prescription COX2 inhibitor nonsteroidal antiinflammatory drug (NSAID). Vioxx works by inhibiting the COX2 form of the COX …
More
Q:What Evidence Supports The Withdrawal? A: Merck's decision to withdraw Vioxx from the market is based on new data from a trial called the APPROVe (Adenomatous Polyp Prevention on VIOXX) trial. In the APPROVe …
More
Q:Why Has Vioxx Been Withdrawn From The Market? A: New research shows that a major Vioxx side effect is a greatly increased risk of cardiovascular (CV) events such as heart attack or stroke if used longterm.
More